Yayınlar & Eserler

ATLAS Yayın Analitiği
Makaleler 58
Tümü (58)
SCI-E, SSCI, AHCI (49)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (3)
Scopus (55)
TRDizin (14)
Diğer Yayınlar (1)

1. Timing and phenotype in refining the role of plasma exchange in amatoxin-induced acute liver failure

Özden Y., TURAN GÖKÇE D.
Critical Care , cilt.30, sa.1, 2026 (SCI-Expanded, Scopus) Creative Commons License

2. Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.

Nikitina D., Suk K. T., Torre A., Idilman R., Alvares-da-Silva M. R., Lauridsen M. M., et al.
Gut , 2026 (SCI-Expanded, Scopus)

3. TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD)

YILMAZ Y., Adali G., Ergenc I., Kaya E., TURAN GÖKÇE D., KEKLİKKIRAN Ç., et al.
Hepatology Forum , cilt.7, sa.3, ss.177-214, 2026 (Scopus) Creative Commons License

4. Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the turkish population: A multicenter study

Moral K., Harputluoğlu M., Özkumur G. F., Gavcar D., Erbay E., EREN F., et al.
Liver Transplantation , cilt.Publish Ahead of Print, 2026 (SCI-Expanded, Scopus)

5. De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes

DANIŞ N., DÖNGELLİ H., ÜNEK T., Bacakoğlu A., Turan İ., Karasu A. Z., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.37, sa.4, ss.510-523, 2026 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

6. From Strain Ratio to Shear-Wave Elastography: Evolving Role of EUS in Liver Fibrosis Assessment.

Kaldirim Armutcuoglu Y., Turan Gokce D.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.37, sa.5, ss.639-640, 2026 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

7. Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort

Silvey S., Choudhury A. K., Kamath P. S., Xie Q., Wong F., Hayes P. C., et al.
American Journal of Gastroenterology , 2026 (SCI-Expanded, Scopus)

8. Endoscopic Transmural Drainage of Walled-off Necrosis: Comparative Outcomes of EUS-guided Versus Conventional Approaches

Ödemiş B., Ünver N. G., Özdemir M., Kenarli K., Macif A., Başpinar B., et al.
Surgical Laparoscopy, Endoscopy and Percutaneous Techniques , 2026 (SCI-Expanded, Scopus)

9. When viral quiescence meets metabolic injury: Rethinking risk and treatment at the intersection of MASLD and chronic hepatitis B

TURAN GÖKÇE D., Akarca U. S.
Hepatology Forum , cilt.7, sa.1, ss.1-3, 2026 (Scopus) Creative Commons License

10. Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis

Adali G., Acar S., Harputluoğlu M., YILMAZ T. U., KARAKAYALI H., Istemihan Z., et al.
Clinical Transplantation , cilt.40, sa.1, 2026 (SCI-Expanded, Scopus)

11. RE: Prophylactic antiviral therapy and all-cause mortality in cancer patients with hepatitis B e antigen-negative chronic hepatitis B virus infection receiving immunosuppressive therapy.

Trak A., Gökçe D.
Journal of the National Cancer Institute , cilt.117, ss.2691-2692, 2025 (SCI-Expanded, Scopus)

12. Utilizing CT-derived extracellular volume fraction to distinguish hepatocellular adenoma from focal nodular hyperplasia.

Beşler M. S., Turan Gökçe D., Turhan N., Ökten R. S.
Medicine , cilt.104, sa.43, 2025 (SCI-Expanded, Scopus)

13. Histological disease progression in patients with metabolic dysfunction–associated steatotic liver disease using paired liver biopsy

Turan Gokce D., Ekelik M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
European Journal of Gastroenterology and Hepatology , 2025 (SCI-Expanded, Scopus)

14. The Effect of Nutritional Education on Nutritional Status and Quality of Life in Patients with Liver Cirrhosis.

Tinkilic S., Turker P. F., Yilmaz C. S., Akdogan Kayhan M., Ari D., Turan Gökce D.
Healthcare (Basel, Switzerland) , cilt.13, sa.15, 2025 (SCI-Expanded, SSCI, Scopus)

15. Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study

Çalışkan A. R., Turan I., Vatansever S., Weninger J., Şamdancı E. T., AKATLI A. N., et al.
Biomedicines , cilt.13, sa.7, 2025 (SCI-Expanded, Scopus)

16. Efficacy and safety of infliximab in patients with autoimmune hepatitis

Efe C., Lytvyak E., EŞKAZAN T., Liberal R., Androutsakos T., Gökçe D., et al.
Hepatology , cilt.81, sa.6, ss.1660-1670, 2025 (SCI-Expanded, Scopus)

17. IMPACT OF BODY MASS INDEX ON SURVIVALOUTCOMES IN HEPATOCELLULAR CARCINOMAPATIENTS TREATED WITH LOCOREGIONAL THERAPIESIN THE MENA REGION

Alzanbagi A., Sanai F., El-Kassas M., Al-Naamani K., DEMİRTAŞ C. Ö., Yapici H. B., et al.
GUT , cilt.74, sa.SUPPL_1, 2025 (SCI-Expanded, Scopus)

18. Letter to the Editor: Should NAFLD be automatically relabeled as MASLD?

TURAN GÖKÇE D., YILMAZ Y.
Hepatology , cilt.81, sa.5, 2025 (SCI-Expanded, Scopus)

19. Investigation of Hepatitis C, D, and HIV Seroprevalence and Evaluation of APRI and FIB-4 Scores in HbsAg-Positive Patients

Akıllı F. M., Özbay Haliloğlu E. N., Güncü M. M., Turan Gökçe D.
Viruses , cilt.17, sa.4, 2025 (SCI-Expanded, Scopus)

20. Kaposi’s sarcoma developing in a geriatric patient with autoimmune hepatitis shortly after immunsupressive treatment

TURAN GÖKÇE D., Ari D., Ozturk O., Kayhan M. A.
Hepatology Forum , cilt.6, sa.2, ss.87-88, 2025 (Scopus, TRDizin)

21. Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis

Eruzun H., Bossen L., TURAN GÖKÇE D., Ergenç İ., Harput Z. N., Aydemir N. G., et al.
Turkish Journal of Gastroenterology , cilt.36, sa.4, ss.241-246, 2025 (SCI-Expanded, Scopus, TRDizin)

22. Determination of the Viremia and Genotype Distribution of the Hepatitis C Virus and the Seroprevalence of HIV Co-Infection

Akıllı F. M., Turan-Gökçe D., Akıllı B.
Infectious Diseases and Clinical Microbiology , cilt.7, sa.1, ss.27-36, 2025 (Scopus, TRDizin)

23. A Case of Difficult-To-Treat Autoimmune Hepatitis Successfully Managed by Tofacitinib

TURAN GÖKÇE D., Arı D., Kayhan M. A., Efe C.
Liver International , cilt.45, sa.2, 2025 (SCI-Expanded, Scopus)

24. Extrahepatic Liver Metastasis in the Follow-Up of Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: Single-Center Experience

Aydın O., Çolakoğlu M. K., TURAN GÖKÇE D., Öter V., Özgün Y. M., Arı D., et al.
Experimental and Clinical Transplantation , cilt.23, sa.2, ss.133-137, 2025 (SCI-Expanded, Scopus)

25. High prevalence of pancreatic steatosis in pancreatic cancer patients: A meta-analysis and systematic review

Vlăduț C., Steiner C., Löhr M., TURAN GÖKÇE D., Maisonneuve P., Hank T., et al.
Pancreatology , cilt.25, sa.1, ss.98-107, 2025 (SCI-Expanded, Scopus)

26. Cirrhosis in Transition: Emerging Concern in a Post-Pandemic World

TURAN GÖKÇE D., Akdogan M.
Turkish Journal of Gastroenterology , cilt.36, sa.1, ss.1-2, 2025 (SCI-Expanded, Scopus, TRDizin)

27. Mushroom Intoxication in Türkiye: A Nationwide Cohort Study Based on Demographic Trends, Seasonal Variations, and the Impact of Climate Change on Incidence

Gökçe D., Ari D., Ata N., GÖKCAN H., İDİLMAN R., Ülgü M. M., et al.
Turkish Journal of Gastroenterology , cilt.36, sa.1, ss.61-66, 2025 (SCI-Expanded, Scopus, TRDizin)

28. Efficacy and safety of double balloon enteroscopy in patients with Peutz-Jeghers Syndrome: Single center experience

YÜKSEL M., YEŞİL B., TURAN D., BACAKSIZ F., TENLİK İ., ÖZTÜRK Ö., et al.
Akademik Gastroenteroloji Dergisi , cilt.23, ss.93-100, 2024 (TRDizin)

29. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

Turan D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
GASTROENTEROLOGY , cilt.166, sa.5, ss.1642, 2024 (SCI-Expanded, Scopus)

30. Tigecycline-Associated Hepatic Steatosis After Liver Transplant: A Case Report

TURAN GÖKÇE D., Arı D., Aydın O., Turhan N., Altunsoy A., Ökten R. S., et al.
Experimental and Clinical Transplantation , cilt.22, sa.4, ss.318-321, 2024 (SCI-Expanded, Scopus)

31. Challenging Conventional Wisdom: Early Treatment and Chronicity Outcomes in Acute Severe Hepatitis B

TURAN GÖKÇE D., Arı D., Yakut M., Kayhan B., Altıparmak E., Altunsoy A., et al.
International Journal of Medical Sciences , cilt.21, sa.15, ss.2974-2980, 2024 (SCI-Expanded, Scopus)

32. Case-based Clinical Reasoning Competitions: A Novel Method to Teach and Assess Clinical Reasoning Skills Among Gastroenterologists

Sadeghi A., Adibi P., ÖNDER F. O., Değertekin B., Turan D., Bor S.
Turkish Journal of Gastroenterology , cilt.35, sa.10, ss.805-807, 2024 (SCI-Expanded, Scopus, TRDizin)

33. Multidrug-Resistant Infections After Liver Transplantation, Etiology and Risk Factors: A Single-Center Experience

Tezcan H., Altunsoy A., Gokce D., GÖKCAN H., Ari D., Aydin O., et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION , cilt.21, sa.12, ss.952-960, 2023 (SCI-Expanded, Scopus)

34. Investigating Whether the Severity of SARS-CoV-2 Infection Is Higher in Liver Transplant Recipients: A Single-Center Experience

TURAN GÖKÇE D., Arı D., Aypak A., Aydın O., Kaçar S., Bostancı E. B., et al.
Experimental and Clinical Transplantation , cilt.21, sa.10, ss.837-840, 2023 (SCI-Expanded, Scopus)

35. Tissue quantitative RT-PCR test for diagnostic significance of cytomegalovirus infection in patients with inflammatory bowel disease and treatment response: Cytomegalovirus infection in patients with inflammatory bowel disease

Ozdemir B., Atay A., Kayhan M. A., Ozin Y. O., TURAN GÖKÇE D., Altunsoy A., et al.
Medicine (United States) , cilt.102, sa.31, 2023 (SCI-Expanded, Scopus)

36. BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

Erol Ç., Kuloğlu Z. E., Kayaaslan B., Esken G., Altunsoy A., Barlas T., et al.
VIRUSES-BASEL , cilt.15, sa.7, 2023 (SCI-Expanded, Scopus) Creative Commons License

37. Identification of risk factors for alcohol relapse in liver transplant patients with alcohol-related liver disease

Turan D., GÜNŞAR F., Harputluoglu M., Kabacam G., Gokcan H., Akyildiz M., et al.
JOURNAL OF HEPATOLOGY , cilt.78, 2023 (SCI-Expanded, Scopus)

38. Pneumatic Dilation in Geriatric Achalasia Patients

Tenlik İ., Öztürk Ö., Özin Y., Arı D., Coşkun O., TURAN GÖKÇE D., et al.
Turkish Journal of Gastroenterology , cilt.34, sa.4, ss.332-338, 2023 (SCI-Expanded, Scopus, TRDizin)

39. Biliary Complications in Living Liver Donors After Donor Hepatectomy: A Single-Center Experience

Aydın O., TURAN GÖKÇE D., Öter V., Arı D., Özgün Y. M., Pişkin E., et al.
Experimental and Clinical Transplantation , cilt.21, sa.2, ss.139-142, 2023 (SCI-Expanded, Scopus)

40. Effect of Pretransplant Sarcopenia on Mortality in Liver Transplant Recipients

Arı D., Dağlı M., GÖKCAN H., Gökçe D., Ökten R. S., Aydın O., et al.
Experimental and Clinical Transplantation , cilt.21, sa.2, ss.123-131, 2023 (SCI-Expanded, Scopus)

41. Diagnosis and Treatment of Autoimmune Hepatitis: Questions, Answers, and Illustrative Cases: Endorsed by Autoimmune Liver Diseases Special Interest Group, Turkish Association for the Study of Liver

Özaslan E., Günşar F., ÇİFCİBAŞI ÖRMECİ A., Hatemi İ., Efe C., AKYOL G., et al.
Turkish Journal of Gastroenterology , cilt.34, 2023 (SCI-Expanded, Scopus, TRDizin)

42. Complete Recovery After Immunosuppressive Treatment Change in a Patient With Posttransplant Lymphoproliferative Disorder

Arı D., Turan D., GÖKCAN H., Özdemir M., Kayhan M. A.
Experimental and Clinical Transplantation , cilt.21, sa.1, ss.76-79, 2023 (SCI-Expanded, Scopus)

43. Rare hepatocellular carcinoma presentation: Hepatoportal sclerosis

Gokce D., Ari D., GÖKCAN H., Aydin O., Turhan N., Kayhan M. A.
HEPATOLOGY FORUM , cilt.4, sa.1, ss.35-36, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

44. Magnetic compression anastomosis using a double-balloon enteroscope for complete obstruction of Roux-en-Y hepaticojejunostomy anastomosis

TURAN GÖKÇE D., Ödemiś B., Erdoǧan Ç.
Endoscopy , cilt.54, 2022 (SCI-Expanded, Scopus) Creative Commons License

45. SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT

Ari D., TURAN GÖKÇE D., Öztürk Ö., Özdemir B., Turhan N., Akdoǧan Kayhan M.
Gastroenterology Nursing , cilt.45, sa.6, ss.449-451, 2022 (SCI-Expanded, SSCI, Scopus)

46. NATURAL DISEASE OUTCOMES IN PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE: A STUDY WITH PAIRED LIVER BIOPSIES

Gumussoy M., Gokce D., Ekelik M., KİREMİTCİ S., Bodakci E., DUMAN S., et al.
HEPATOLOGY , cilt.76, 2022 (SCI-Expanded, Scopus)

47. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Efe C., Taşçılar K., Gerussi A., Bolis F., Lammert C., Ebik B., et al.
Journal of Autoimmunity , cilt.132, 2022 (SCI-Expanded, Scopus)

48. Characteristics of patients with hepatocellular carcinoma: A multicenter study

Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM , cilt.3, sa.3, ss.71-76, 2022 (ESCI, Scopus, TRDizin) Creative Commons License

49. Global multi-stakeholder endorsement of the MAFLD definition

Méndez-Sánchez N., Bugianesi E., Gish R. G., Lammert F., Tilg H., Nguyen M. H., et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY , cilt.7, sa.5, ss.388-390, 2022 (SCI-Expanded, Scopus)

50. Evaluation of esophageal motor functions in patients diagnosed with primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis

Gokbulut V., Ozturk O., Akdogan M., Kaplan M., GÖKCAN H., Kacar S., et al.
CUKUROVA MEDICAL JOURNAL , cilt.47, sa.1, ss.21-28, 2022 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

51. Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients

Bacaksiz F., GÖKCAN H., Akdogan M., Gokce D., Ari D., Gokbulut V., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.12, 2021 (SCI-Expanded, Scopus)

52. Association between non-alcoholic fatty liver disease and extrahepatic malignancy

Gumussoy M., İDİLMAN R., GÖKCAN H., Gokce D., Ulas B. B., Koc O., et al.
JOURNAL OF HEPATOLOGY , cilt.75, 2021 (SCI-Expanded, Scopus)

53. Covid-19 in Liver Transplant Recipients: A National Cohort

Kabacam G., TURAN İ., KIYICI M., Ellik Z., DOLU S., Dayangac M., et al.
JOURNAL OF HEPATOLOGY , cilt.75, 2021 (SCI-Expanded, Scopus)

54. Wire-guided over-the-scope clip method for closing gastrobronchial fistula

Odemis B., TURAN GÖKÇE D.
ENDOSCOPY , cilt.53, sa.02, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis

Cox I. J., İDİLMAN R., Fagan A., Turan D., Ajayi L., Le Guennec A. D., et al.
LIVER INTERNATIONAL , sa.2, ss.416-427, 2020 (SCI-Expanded, Scopus)

56. Effectiveness of fixed-dose combination of paritaprevir, ritonavir, ombitasvir, and dasabuvir in patients with chronic hepatitis C virus infection and chronic kidney diseases: real-life experiences

Ormeci N., SEZGİN O., KARAALİ R., AYGEN B., Turan D., YARAŞ S., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , sa.4, ss.534-539, 2019 (SCI-Expanded, Scopus)

57. Risk factors for thrombosis risk in patients with cancer

TURAN D., YAŞAR H. A., Aksu O. B., KÖKSOY E. B., UTKAN G., AKBULUT H., et al.
Journal of Oncological Sciences , cilt.4, sa.3, ss.130-133, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

58. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort

Bajaj J. S., İDİLMAN R., Mabudian L., Hood M., Fagan A., Turan D., et al.
HEPATOLOGY , sa.1, ss.234-247, 2018 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 34

1. Liver disease severity in index patients with matabolic dysfunction-associated steatotic liver disease predicts the disease in first-degree relatives: acall for targeted screening

TURAN GÖKÇE D., TUNÇ E., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., GÖKCAN H., İDİLMAN R.
EASL Congress, Barcelona, İspanya, 27 - 30 Mayıs 2026, cilt.84, ss.519-520, (Özet Bildiri)

2. PNPLA3 I148M Homozigot Mutasyonunun Hepatoselüler Kanser Hastalık Seyrine Etkisi

TURAN GÖKÇE D., TUNÇ E., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., ER R. E., GÖKCAN H., et al.
17. ULUSAL HEPATOLOJİ KONGRESİ, Antalya, Türkiye, 14 - 17 Mayıs 2026, (Özet Bildiri)

3. Metabolik Disfonksiyonla İlişkili Yağlı Karaciğer Hastalığı (MASLD) Olan İndeks Hastalarda İleri Evre Fibrozis, Birinci Derece Akrabalardaki MASLD Riskini Güçlü Biçimde Öngörmektedir: Hedefe Yönelik Tarama İçin Bir Çağrı

TURAN GÖKÇE D., TUNÇ E., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., GÖKCAN H., İDİLMAN R.
17. ULUSAL HEPATOLOJİ KONGRESİ, Antalya, Türkiye, 14 - 17 Mayıs 2026, (Özet Bildiri)

4. Alkol İlişkili Karaciğer Hastalığı Olan Hastalarda Non – İnvaziv Fibrozis Testlerinin Hastalık Sonuçlarını Öngörme Performansı

TURAN GÖKÇE D., MELEKOĞLU ELLİK Z., TUNÇ E., GÜMÜŞSOY M., GÖKCAN H., İDİLMAN R.
17. ULUSAL HEPATOLOJİ KONGRESİ, Antalya, Türkiye, 14 - 17 Mayıs 2026, (Özet Bildiri)

5. Hepatocellular carcinoma in the MENA region differs in presentation and outcomes: an analysis of 2736 patients from Saudi Arabia, Oman, Egypt and Turkiye

Sanai F. M., DEMİRTAŞ C. Ö., Khalid A. N., Alzanbagi A., Elbadry M., Yilmaz Y., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)

6. WIDE VARIATIONS IN ANTIMICROBIAL GENE CARRIAGE IN PATIENTS WITH CIRRHOSIS AND HEALTHY CONTROLS FROM 7 COUNTRIES WITH 1020 PARTICIPANTS: IMPLICATIONS FOR RESISTANT INFECTIONS

Bajaj J. S., Kupcinskas J., Kreivenaite E., Suk K. T., Sharma S., Lee H. W., et al.
Digestive Disease Week, California, Amerika Birleşik Devletleri, 3 - 06 Mayıs 2025, cilt.169, (Özet Bildiri)

7. Gut metagenomic profiles predict 90-day hospitalizations despite controlling for diet, demographics & cirrhosis details in a multi-country cohort of patients with cirrhosis

Bajaj J., Nikitina D., Sikaroodi M., Alvares-da-Silva M., Torre A., Suk K. T., et al.
European-Association-for-the-Study-of-the-Liver Congress, Amsterdam, Hollanda, 7 - 10 Mayıs 2025, cilt.82, (Özet Bildiri)

8. DIFFERENTIATING EARLY-STAGE CIRRHOSIS FROM NON-CIRRHOTIC PORTAL HYPERTENSION USING NONINVASIVE DIAGNOSTIC TESTS

TURAN GÖKÇE D., Ari D., İDİLMAN İ. S., Akdogan M.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, cilt.80, (Özet Bildiri)

9. Clinical and biochemical characteristics of a Danish and Turkish cohort of incident and prevalent patients with primary biliary cholangitis

Eruzun H., Bossen L., TURAN GÖKÇE D., Ergenc I., Harput Z. N., Aydemir N. G., et al.
European-Association-for-the-Study-of-the-Liver Congress (EASL), Milan, İtalya, 5 - 08 Haziran 2024, cilt.80, (Özet Bildiri)

10. Requrrence of primary sclerosing cholangitis after living donor liver transplantation: experience from turkish registery

ADALI G., harputluoğlu m., AKDOĞAN KAYHAN M., TURAN D., AKARSU M., DANIŞ N., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)

11. Histological and clinical disease progression in patients with metabolic associated steatotic liver disease using paired biopsy

ekelik m., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., yılmaz V., et al.
EASL congress 2024, 05 Haziran 2024, (Özet Bildiri)

12. DISEASE PROGRESSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE USING PAIRED LIVER BIOPSY

TURAN GÖKÇE D., Ekelik M. M., Gumussoy M., Kiremitci S., Bodakci E., Yilmaz V., et al.
Digestive Disease Week (DDW), Washington, Kiribati, 18 - 21 Mayıs 2024, cilt.166, (Özet Bildiri)

13. Histological and Clinical disease Progression in Patients with Metabolic Dysfuntion associated Steatotic Liver Disease Isinig Paired Biopsy

Ekelik M. M., TURAN D., GÜMÜŞSOY M., KİREMİTCİ S., BODAKÇİ E., YILMAZ V., et al.
AASLD-TASL hepatology connect meeting 2024, 16 Şubat 2024, (Özet Bildiri)

14. Noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan D., DUMAN S., MELEKOĞLU ELLİK Z., GÜMÜŞSOY M., et al.
AASLD 2023 congress, Amerika Birleşik Devletleri, 10 Kasım 2023, (Özet Bildiri)

15. noninvazive fibrosis markers for assesment for liver fibrosis in patients with chronic hepatitis delta

KARAKAYA M. F., KURU ÖZ D., Turan Gökçe D., DUMAN S., Ellik Z. M., GÜMÜŞSOY M., et al.
AASLD 2023 congress, 10 Kasım 2023, (Tam Metin Bildiri)

16. NON - INVASIVE FIBROSIS MARKERS FOR ASSESMENT OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS DELTA

BODAKÇİ E., KARAKAYA M. F., KURU ÖZ D., Gokce D., DUMAN S., Ellik Z., et al.
Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 10 - 14 Kasım 2023, cilt.78, (Özet Bildiri)

17. UNTARGETED METABOLOMICS APPROACH FOR ACUTE PANCREATITIS: SEARCHING FOR POTENTIAL MARKERS USING UPLC-Q-TOF-MS

TURAN GÖKÇE D., Celebier M., KAPLAN O., Ari D., Fidan B. B., Ors E., et al.
Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, cilt.164, (Özet Bildiri)

18. Natural Disease outcome in patients with NAFLDÇ a study with paired liver biopsies

GÜMÜŞSOY M., TURAN D., ekelik m., KİREMİTCİ S., DUMAN S., GÜVENİR S. T., et al.
AASLD-TASL hepatology connect meeting, 28 Nisan 2023, (Tam Metin Bildiri)

19. İdentification of risk factors for alcohol relapse in liver transplant patients with alcohol- related liver disease.

TURAN D., GÜNŞAR F., harputluoğlu m., KABAÇAM G., GÖKCAN H., AKARSU M., et al.
EASL Congress 21-24 June 2023, 21 Nisan 2023, (Tam Metin Bildiri)

20. Alkol Dışı Yağlı Karaciğer Hastalığı Doğal Seyri: Ardışık İkili Karaciğer Biyopsilerinin Karşılaştırılması

GÜMÜŞSOY M., TURAN D., EKELİK M., KİREMİTCİ S., BODAKÇİ E., DUMAN S., et al.
39. ULUSAL GASTROENTEROLOJİ HAFTASI, Antalya, Türkiye, 22 Kasım 2022, (Özet Bildiri)

21. Natural disease Outcome in patients with NAFLD: A study with paired liver biopsy

GÜMÜŞSOY M., Turan Gökçe D., KİREMİTCİ S., BODAKÇİ E., DUMAN S., MELEKOĞLU ELLİK Z., et al.
aasld 2022, 04 Kasım 2022, (Özet Bildiri)

22. Detection of early-stage hepatosteatosis after liver transplantation with MRI-PDFF

TURAN GÖKÇE D., Ari D., Trak A., Ozdemir A., Kayhan M. A.
Joint Annual International Congress of ILTS, ELITA and LICAGE, İstanbul, Türkiye, 4 - 07 Mayıs 2022, cilt.106, ss.190, (Özet Bildiri)

23. The analysis of liver transplant patients with COVİD-19 infection: a national cohort

KABAÇAM G., TURAN İ., KIYICI M., MELEKOĞLU ELLİK Z., dolu S., Dayangaç M., et al.
AASLD-TASL digital Hepatology Connect, İstanbul, Türkiye, 15 - 16 Ocak 2021, cilt.2, ss.24-25, (Özet Bildiri)

24. Non-alcoholic fatty liver disease and extrahepatic malignancy

Gümüşsoy M., Turan Gökçe D., Ulaş B. B., Koç Ö., Karataş G., Bodakçı E., et al.
AASLD-TASL digital Hepatology Connect, 15 Ocak 2021, (Tam Metin Bildiri)

25. Direkt Etkili Antiviral Ajanlarla Tedavi Olan Hepatit C Hastalarında Noninvaziv Fibrozis İndeks Değerlerinin Değişimi

ARI D., TURAN GÖKÇE D., GÖKCAN H., BACAKSIZ F., ÖZTÜRK Ö., KACAR S., et al.
37. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2020, (Özet Bildiri)

26. ASSOCIATION BETWEEN NON-ALCOHOLOIC FATTY LIVER DISEASE AND SUBCLINICAL ATHEROSCLEROSIS AND MYOCARDIAL DYSFUNCTION USING MULTIMODALITY IMAGING

ULAŞ B. B., ÖZYÜNCÜ N., ÇALIŞKAN KARTAL A., PEKER E., TURAN GÖKÇE D., GÜMÜŞSOY M., et al.
ANNUAL MEETING OF AASLD / LIVER MEETING, 8 - 12 Kasım 2019, (Tam Metin Bildiri)

27. ASSOCIATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND SUBCLINICAL ATHEROSCLEROSIS AND MYOCARDIAL DYSFUNCTION USING MULTIMODALITY IMAGING

Ulas B. B., ÖZYÜNCÜ N., Kartal A. C., PEKER E., Gokce D., Gumussoy M., et al.
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Massachusetts, Amerika Birleşik Devletleri, 8 - 12 Kasım 2019, cilt.70, (Özet Bildiri)

28. Plasma metabolomic changes modulate the impact of Middle Eastern versus Western Diet in an international cirrhosis cohort

Cox I. J., İDİLMAN R., Fagan A., Turan D., Ajayi L., Karakaya F., et al.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)

29. Bevacizumab İlişkili Trombotik Mikroanjiyopati: Vaka Sunumu

KUMRU G., KUBİLAY TOLUNAY P., Turan Gökçe D., Güleç B., UTKAN G., ŞENGÜL Ş.
20. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, Kıbrıs (Kktc), 9 - 13 Mayıs 2018, (Tam Metin Bildiri)

30. DIET AFFECTS GUT MICROBIOTA AND MODULATES HOSPITALIZATION RISK DIFFERENTIALLY IN AN INTERNATIONAL CIRRHOSIS COHORT

Bajaj J. S., Idiliman R., Mabudian L., Hood M., Fagan A., TURAN GÖKÇE D., et al.
Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, Washington, Kiribati, 2 - 05 Haziran 2018, cilt.154, (Özet Bildiri)

31. Geraitrik hastalarda trombosit indeksleri, nötrofillenfosit oranı, trombosit-lenfosit oranının kolon kanseri ve kolon polibi ayrırımındaki başarısı

KARAKAYA M. F., TURAN D., KARAKAYA M., KALKAN Ç., SOYKAN A. İ.
14. Ulusal Hepato-Gastroenteroloji Kongresi, Antalya, Türkiye, 05 Nisan 2017, (Özet Bildiri)

32. P1483 THE PREDICTIVE VALUE OF FERRITIN IN OLDER PATIENTS IN THE DIAGNOSIS OF COLON CANCER

KARAKAYA M. F., KALKAN Ç., TURAN D., KARAKAYA M. G., ÇALIŞKAN KARTAL A., SOYKAN A. İ.
United European Gastroenterology Week 2016, 17 - 19 Ekim 2016, (Özet Bildiri)

33. The predictive value of ferritin in older patients in the diagnosis of colon cancer

KARAKAYA M. F., KALKAN Ç., TURAN D., ÇALIŞKAN KARTAL A., SOYKAN A. İ.
united european gastroenterolog week 2016, 15 - 18 Ekim 2016

34. The evaluation of esophageal functions by manometry in iron deficiency anemia patients

Bektas M., Kubilay P., Karakaya F., Turan D., Tuzun A., Yurdaydin C., et al.
NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, cilt.27, ss.42, (Özet Bildiri)
Metrikler

Yayın

92

Yayın (WoS)

68

Yayın (Scopus)

55

Atıf (WoS)

515

H-İndeks (WoS)

10

Atıf (Scopus)

584

H-İndeks (Scopus)

10

Atıf (Scholar)

589

H-İndeks (Scholar)

8

Atıf (TrDizin)

15

H-İndeks (TrDizin)

2

Atıf (Diğer Toplam)

15

Proje

1

Açık Erişim

10
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER